Industry & Litigation Updates
NEC Baby Formula Litigation: What Attorneys Need From Medical Experts
825 actions are pending in MDL 3026 as of the August 3, 2026 JPML report. A look at the NEC preterm formula litigation, the science, and the neonatology, pediatric GI, pediatric surgery, and NICU nursing experts these cases require.
Read More...
When the Diagnosis Was Right but the Message Never Arrived
A $75 million Georgia verdict and a decade of claims data show why communication failures now drive medical malpractice cases, and how attorneys should build them.
Read More...Depo-Provera and Meningioma Litigation: What Attorneys Need From Medical Experts
Nearly 6,000 federal lawsuits allege that Pfizer’s Depo-Provera caused meningiomas, a type of brain tumor. With a global settlement framework signed and Rule 702 hearings approaching for non-settling claims, the demand for qualified neurosurgery, neuroradiology, and OB/GYN expert witnesses continues to grow.
Read More...
GLP-1 Receptor Agonist Litigation: What Attorneys Need From Medical Experts
More than 4,000 federal lawsuits allege that GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound caused severe gastrointestinal injuries. With Rule 702 hearings scheduled for September 2026, the demand for qualified gastroenterology, endocrinology, and pharmacology expert witnesses is surging.
Read More...
Increasing Liability: Hip Fractures in Hospitals and Nursing Homes
More than 14.2 million people worldwide experience a hip fracture each year. Patient falls resulting in hip fractures are considered Sentinel Events by the Joint Commission, posing significant risk for negligence and medical malpractice litigation.
Read More...